PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a $77.5 million market cap company known for its focus on non-opioid pain management products, reported that the U.S. Food and Drug ...

Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering hope to thousands of patients.

Gout tophi totally disappeared and renal function remained stable. The patient continues to receive rasburicase treatment. P Richette is a Rheumatologist and T Bardin is a Professor of ...

PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a pharmaceutical company with a current market capitalization of ...

For patients with gout who cannot get relief ... Now, phase 3 results with a new drug from Sobi and Selecta suggests there could be another treatment option in the offing. Armed with a pair ...

In a significant milestone for Ayurvedic medicine, Amrith Noni has successfully completed human clinical trials for its ...

Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...

A person should discuss further treatment options ... kidney stones and flare-ups of gout. A person should always speak with a doctor before embarking on a new diet, especially one that aims ...

CALGARY, Alberta, Jan. 17, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), ...

15, 2025 — Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used ...

Could a Dietary Fiber Supplement Offer Long-Awaited Treatment for Food Allergy Sufferers? July 9, 2024 — A study has identified a potential new treatment for food allergies in inulin ...